can you take omeprazole with semaglutide Understanding Long-Term Side Effects of These highlights do not include
Description
Tirzepatide Bigger Results, Bigger Buzz Why it's popular: Tirzepatide (Mounjaro/Zepbound) is a dual GLP-1/GIP agonist that outperformed semaglutide head-to-head, reaching about 20.9% weight loss in SURMOUNT-1 ( Jastreboff et al., NEJM 2022 )
Most protocols begin with a low dose (0.25 mg weekly) to minimize nausea, then increase gradually over 48 weeks
GLP-1 , , , ,
Yesapproximately 1525% of patients experience minimal or no nausea from semaglutide, particularly those carrying specific GLP1R genetic variants that reduce medication sensitivity
GLP-1 nedstter appetitten, og patienterne taber sig i vgt
